Oncologists from the Neuroblastoma and Medulloblastoma Translational Research Consortium and biomedical researchers from TGen will utilize the cloud technology to identify targeted treatments for pediatric cancer patients based on the specific genetic vulnerabilities of each child's tumor, according to Dell.

Dell said the computational performance of the cluster is expected to accelerate analysis and identification of targeted treatments beyond initial projections.